Title:
CANCER THERAPEUTIC AGENT
Document Type and Number:
WIPO Patent Application WO/2023/022141
Kind Code:
A1
Abstract:
Provided is a cancer therapeutic agent for cancer tissues including CD209 positive cells. This cancer therapeutic agent for cancer tissues including CD209 positive cells, comprises gel particles containing a modified polysaccharide including a hydrophobic group.
Inventors:
HARADA NAOZUMI (JP)
AKIYOSHI KAZUNARI (JP)
SAWADA SHIN-ICHI (JP)
MURAOKA DAISUKE (JP)
AKIYOSHI KAZUNARI (JP)
SAWADA SHIN-ICHI (JP)
MURAOKA DAISUKE (JP)
Application Number:
PCT/JP2022/030928
Publication Date:
February 23, 2023
Filing Date:
August 16, 2022
Export Citation:
Assignee:
UNITED IMMUNITY CO LTD (JP)
International Classes:
A61K47/36; A61K9/51; A61K39/00; A61K39/39; A61K45/00; A61P35/00; B82Y5/00
Domestic Patent References:
| WO2017138557A1 | 2017-08-17 | |||
| WO2000012564A1 | 2000-03-09 |
Other References:
FRAFJORD ASTRI, SKARSHAUG RENATE, HAMMARSTRÖM CLARA, STANKOVIC BRANISLAVA, DORG LINDA T., AAMODT HENRIK, WOLDBÆK PER REIDAR, HELLA: "Antibody combinations for optimized staining of macrophages in human lung tumours", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, BLACKWELL SCIENCE PUBL., OXFORD, GB, vol. 92, no. 1, 1 July 2020 (2020-07-01), GB , XP093037422, ISSN: 0300-9475, DOI: 10.1111/sji.12889
WANG YUTAO, YAN KEXIN, WANG JIANFENG, LIN JIAXING, BI JIANBIN: "M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer", FRONTIERS IN ONCOLOGY, vol. 11, XP093037423, DOI: 10.3389/fonc.2021.609334
NAKATSUKASA, TAKAAKI: "Search for target antigens of tumor-associated macrophages directivity DDS and development of novel immunotherapy", NAGASAKI MEDICAL ASSOCIATION BULLETIN, no. 914, 28 February 2022 (2022-02-28), pages 31 - 32, XP009543581
MURAOKA, D ET AL., ACS NANO, vol. 8, no. 9, 2014, pages 9209 - 9218
MACROMOLECULES, vol. 23, 1993, pages 3062 - 3068
WANG YUTAO, YAN KEXIN, WANG JIANFENG, LIN JIAXING, BI JIANBIN: "M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer", FRONTIERS IN ONCOLOGY, vol. 11, XP093037423, DOI: 10.3389/fonc.2021.609334
NAKATSUKASA, TAKAAKI: "Search for target antigens of tumor-associated macrophages directivity DDS and development of novel immunotherapy", NAGASAKI MEDICAL ASSOCIATION BULLETIN, no. 914, 28 February 2022 (2022-02-28), pages 31 - 32, XP009543581
MURAOKA, D ET AL., ACS NANO, vol. 8, no. 9, 2014, pages 9209 - 9218
MACROMOLECULES, vol. 23, 1993, pages 3062 - 3068
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: